Effects of Carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy

American Journal of Cardiology

Volumn 78, Issue 7, 1996, Pages 779-784

  Quaife, Robert A ^a   Gilbert, Edward M ^b   Christian, Paul E ^b   Datz, Fred L ^b   Mealey, Patrice C ^b   Volkman, Kirk ^b   Olsen, Stephanie L ^b   Bristow, Michael R ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAZOLE DERIVATIVE; CARVEDILOL; PROPANOLAMINE DERIVATIVE;

ARTICLE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART RATE; HEART STROKE VOLUME; HEART VOLUME; HEMODYNAMICS; HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SYSTOLE;

ADRENERGIC BETA-ANTAGONISTS; CARBAZOLES; CARDIAC VOLUME; CARDIOMYOPATHY, DILATED; DIASTOLE; DOUBLE-BLIND METHOD; FEMALE; HEART CATHETERIZATION; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROPANOLAMINES; PROSPECTIVE STUDIES; STROKE VOLUME; SYSTOLE; VENTRICULAR FUNCTION, LEFT;

EID: 0030267603     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00420-1     Document Type: Article

References (29)

1. Gilbert EM, Anderson JL, Deitchman D, Yanowitz FG, O'Connell JB, Renlund DG, Bartholomew M, Mealey PC, Larrabee P, Bristow MR. Long-term β-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo. Am J Med 1990;88:223-229.
2. Bristow MR, O'Connell JB, Gilbert EM, French WJ, Leatherman G, Kantrowitz NE, Orie J, Smucker ML, Marshall G, Kelly P, Deithman D, Anderson JL, for the Bucindolol Investigators. Dose-response of chronic β-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Circulation 1994;89:1632-1642.
3. Anderson JL, Gilbert EM, O'Connell JB, Renlund D, Yanowitz F, Murry M, Roskelley, Mealey P, Volkman K, Deitchman D, Bristow, MR. Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopethy. J Am Coll Cardiol 1991;17:1373-1381.
4. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson A. For the Metoprolol in Dilated Cardoypathy Trial Study Group. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993;342:1441-1446.
5. Eichhorn EJ, Bedotto JB, Malloy CR, Hatfield BA, Deitchman D, Brown M, Willard JE, Grayburn PA. Effect of β-adrenergic blockade on myocardial function and energetics in congestive heart failure: improvements in hemodynamic, contractile and diastolic performance with bucindolol. Circulation 1990; 82:473-483.
6. Eichhorn EJ, Heesch CM, Barnett JH, Alvarez LG, Fass SM, Grayburn PA, Hatfield BA, Marcoux LG, Malloy CR. Effects of metoprolol on myocardial function and energetics in patients with non-ischemic dilated cardiomyopathy: a randomized double-blind, placebo-controlled study. J Am Coll Cardiol 1994;24:1310-1320.
7. Wisenbaugh T, Katz I, Davis J, Essop R, Skoularigis J, Middlemost S, Rothlisberger C, Skudicky D, Sareli P. Long-term (3-month) effects of a new betablocker (nebivolol) on cardiac performance in dilated cardiomyopathy. J Am Coll Cardiol 1993;21:1094-1100.
8. Bristow MR. Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents. Am J Cardiol 1993;71:12c-22c.
9. Das Gupta P, Broadhurst P, Raftery EB, Lahiri A. Value of carvedilol in congestive heart failure secondary to coronary artery disease. Am J Cardiol 1990;66:1118-1123.
10. Metra M, Nardi M, Giubbini R, Dei Cas L. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1994:1678-1687.
11. Olsen SL, Gilbert EM, Renlund DG, Taylor DO, Yanowitz FD, Bristow MR. Carvedilol therapy improves LV function and symptoms in heart failure: a double-blind randomized study. J Am Coll Cardiol 1995;25:1225-1231.
12. Bonow, RO, Bacharach SL, Green, MV, Kent KM, Rosing DR, Lipson LC, Leon MB, Epstein SE. Impaired LV diastolic filling in patients with coronary artery disease: assessment with radionuclide angiography. Circulation 1981;64:315-323.
13. Lee FA, Fetterman R, Zaret BL, Wackers FJ. Radi onuclide-derived systolic and diastolic cardiac function using cycle-dependent background correction and Fourier analysis. IEEE Comput Cardiol 1985;4:5-6.
14. Dehmer GJ, Lewis SE, Hillis LD, Twieg D, Falkoff M, Parkey RW, Willerson JT. Non-geometric determination of LV volumes from equilibrium blood pool scans. Am J Cardiol 1980;45:293-300.
15. Slutsky R, Karlinger J, Ricci D, Kaiser R, Pfisterer M, Gordon D, Peterson K, Ashburn W. Left ventricular volumes by gated equilibrium angiography: a new method. Circulation 1979;60:556-564.
16. Links JM, Becker LC, Shindledecker G, Guzman P, Burow RD, Nickoloff EL, Anderson PO, Wagner HN. Measurement of absolute LV volume from gated blood pool studies. Circulation 1982;65:82-90.
17. Miller TR, Goldman KJ, Sampathkumaran KS, Biello DR, Ludbrook PA and Sobel BE. Analysis of cardiac diastolic function: application in coronary artery disease. J Nucl Med 1983;24:2-7.
18. Waagstein F, Hjalmarson A, Varnaukas E, Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975;37:1022-1036.
19. Udelson JE, Bacharach SL, Cannon RO, Bonow RO. Minimum LV pressure during β-adrenergic stimulation in human subjects. Circulation 1990;82:1174-1182.
20. 1-adrenergic receptor partial agonist xamoterol on LV diastolic function. Circulation 1990;81III:87-98.
21. Pouleur H, Eyll C, Hanet C, Cheron P, Charlier AA, Rousseau MF. Long-term effects of xamoterol on LV diastolic function and late remodeling: a study in patients with anterior myocardial infarction and single-vessel disease. Circulation 1988;77:1081-1089.
22. Hershberger RE, Wynn JR, Sundberg L, Bristow MR. Mechanism of action of bucindolol in human ventricular myocardium. J Cardiovasc Pharmacol 1990;15:959-967.
23. Bareiss P, Facello A, Constantinesco A, Demangeat JL, Brunot B, Arbogast R, Roui G. A Iterations in LV diastolic function in chronic ischemic heart failure. Circulation 1990;81(suppl III):III-71-III-77.
24. Hall SA, Cigarroa CG, Marcoux L, Risser RC, Grayburn PA, Eichhorn EJ. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol 1995;24:1154-1161.
25. Udelson JE, Bonow RO. Radionuclide angiographic evaluation of LV diastolic function. In: Gaasch WH, LeWinter MM, eds. Left Ventricular Diastolic Dysfunction in Heart Failure. Philadelphia: Lea & Febiger, 1994;167-186.
26. Plotnick GD, Vogel RA. Noninvasive evaluation of diastolic function: need for hemodynamically and clinically relevant variables. J Am Coll Cardiol 1989;13:1015-1016.
27. Betocchi S, Bonow RO, Bacharach SL, Rosing DR, Maron BJ, Green MV. Isovolumic relaxation period in hypertrophic cardiomyopathy: assessment by radionucli de angiography. J Am Coll Cardiol 1986;7:74-81.
28. Wagner RH, Halama RJ, Henkin RE, Dillehay GL, Sobotka PA. Errors in the determination of LV functional parameters. J Nucl Med 1989;30:1870-1874.
29. McCallister SH, Juni JE, Hibbelin JF, Starling MR. Effects of alterations in systolic pressure on radionucli de measurements of LV filling dynamics. J Nucl Med 1993;34:747-753.